Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -56.30% vs 26.75% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -34.39% vs 261.78% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 108.74% vs 1.50% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -48.35% vs 320.68% in Mar 2024
Compare Profit and Loss Results of Shukra Pharma.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
32.00
451.00
-419.00
-92.90%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
32.00
451.00
-419.00
-92.90%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
0.00
-3.00
0%
Raw Materials Consumed
11.00
223.00
-212.00
-95.07%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
6.00
59.00
-53.00
-89.83%
Operating Expenses
0.00
6.00
-6.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
77.00
-77.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
4.00
-4.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
393.00
-374.00
-95.17%
Operating Profit (PBDIT) excl Other Income
12.00
58.00
-46.00
-79.31%
Other Income
4.00
17.00
-13.00
-76.47%
Operating Profit (PBDIT)
16.00
75.00
-59.00
-78.67%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
16.00
75.00
-59.00
-78.67%
Depreciation
3.00
6.00
-3.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
69.00
-56.00
-81.16%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
69.00
-56.00
-81.16%
Provision for Tax
3.00
18.00
-15.00
-83.33%
Profit After Tax
9.00
50.00
-41.00
-82.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
37.00
236.00
-199.00
-84.32%
Profit Available for appropriations
47.00
287.00
-240.00
-83.62%
Appropriations
47.00
287.00
-240.00
-83.62%
Equity Dividend (%)
1%
460%
-459.00
Earnings Per Share
0.22
17.58
-17.36
-98.75%
Profit And Loss - Net Sales
Net Sales 32.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -56.30% vs 26.75% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -34.39% vs 261.78% in Mar 2024
Profit And Loss - Interest
Interest 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 108.74% vs 1.50% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 9.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.35% vs 320.68% in Mar 2024
